Fiche centre
The George Institute for Global Health
Sydney — Australia
Essais liés3clinical trials
VilleSydneylocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07687056
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Theophylline | SEP | Phase 4 | NCT02261727 | TASCS — Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study | COMPLETED |
| Tenecteplase | Accident vasculaire cérébral | Phase 3 | NCT06320431 | ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | RECRUITING |
| Tenecteplase or Alteplase- depending upon availability at each treating centre | Accident vasculaire cérébral | Phase 3 | NCT07687056 | ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | RECRUITING |